Blog (Page 10)

Understanding the role of PSA In Prostate Cancer Oncologist-Patient Dialogue

The prostate-specific antigen (PSA) score has become a critical post-diagnosis tool for oncologists as they discuss prostate cancer disease state with their patients along with their families and caregivers. Oncologist-patient relationships are based

Covid-19

Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity

A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities

Customer Engagement

Exploring Factors Influencing Individualized Treatment: Breast Cancer

Oncologists often develop individualized treatment plans to ensure patients are receiving care tailored to their situation. Here are factors influencing their decisions.

Covid-19

Impact of COVID-19 on Therapeutic Approaches to Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Understand how neurology departments across the US and Canada are rapidly adapting their clinical care delivery systems to minimize risk of SARS-CoV-2 transmission.

Conferences

ASCO20 Delivered Practice-Changing Data in a Highly Accessible, Virtual Format; Despite Reduced Levels of Engagement among Oncologists

Despite the disruption and transition to a completely virtual format, 2020 was not an off-year for ASCO. Nearly all oncologists who attended this year’s ASCO Annual Meeting felt that it represented at

Covid-19

COVID-19: Physician Perspective on Efforts to Address Health Inequity

Evidence shows that the ongoing COVID-19 pandemic disproportionately impacts Black Americans. Here are some recommendations from physicians to advocate for heath equity.

Customer Engagement

Meeting Physician Demand for High Quality Virtual Interactions

Pharmaceutical manufacturers and physicians have a mutual interest in virtual interactions, indicating a long-term shift in current models of engagement.

Covid-19

Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity

Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on

Conferences

ASCO20 Moves From McCormick Place: Oncologists Prepare for a Virtual Meeting

With the ASCO 2020 Annual Meeting just days away, oncologists are nearly universally planning to “attend” this year’s virtual meeting. However, their participation in the meeting will be less in real-time and

Covid-19

Telemedicine and Breast Cancer Patient Care during the COVID-19 Pandemic: Oncologists' Perspective

COVID-19 has served as a catalyst for the rapid uptake of telemedicine across a range of therapeutic categories. Initially, physicians adopted telemedicine, despite uncertainty surrounding reimbursement, in order to ensure the safety of

Customer Engagement

A New Approach for Healthcare Dialogue Research

Often, traditional research doesn't answer all questions pertaining to clinical treatment decisions. Here's ZoomRx's new approach to address such questions.

Covid-19

COVID-19 Impact on US Commercial Payers

Throughout the COVID outbreak, health plans have collectively gone to great lengths to provide coverage in an urgent and unexpected situation. Plans have rapidly adapted to current healthcare needs...

Customer Engagement

How MDs are discussing migraine treatment options with patients

Since 2018, the migraine treatment landscape has changed dramatically, with two new approvals in the month of February alone (Vyepti, Nurtec ODT). In light of these developments, we were curious about how migraine

Covid-19

COVID-19: Impact on Healthcare Practices and Treatment Decisions

The evolving COVID-19 pandemic is causing enormous impact on individuals and the healthcare system. Increasingly, it is also clear that COVID-19 has broad-ranging effects on our workplaces, our economy, and our social interactions.

Conferences

AAN 2020 Abstracts Released - What We're Watching in Multiple Sclerosis

As of March 13, the AAN annual meeting has been cancelled due to the ongoing global COVID-19 (Coronavirus) pandemic. We'll be keeping a close eye on any plans to hold events digitally and

Conferences

Treating migraine was a major topic at AAPM 2020 - Here’s how migraine treaters perceive the anti-CGRPs

While opioid abuse deterrence and deprescribing topics were again center stage at the American Academy of Pain Medicine (AAPM) Annual Meeting this year—held February 26-March 1 in National Harbor, MD—headache and

Customer Engagement

Embracing Agility in Pharma Market Research

The following is based on a presentation given by ZoomRx at the Pharma Market Research Conference in Newark, NJ on Feb 5-6, 2020. Please reach out via the form at the bottom of

Promotional Tracking

How 5 Lessons from Rare disease Market Research Apply to Patient Segments in Common Diseases

The continued growth of personalized medicine and other treatment trends presents new challenges for market researchers. Within patient populations that were once considered relatively homogenous, new, smaller patient subgroups are being identified as

Conferences

ASH 2019: Hem-oncs share their perspective on the latest in MM and CLL treatment among other key topics

Nearly 30,000 hematology specialists gathered for this year’s 2019 American Society of Hematology (ASH) annual meeting held Dec 7-10 in Orlando, Florida. This year’s conference delivered on its promise to

Conferences

Getting ready for ASH 2019: Perspective from the ZoomRx hem-onc panel

The ASH 2019 Annual Meeting kicks-off this Saturday (12/7) in Orlando. Our survey of 51 practicing hematologists-oncologists indicated a great deal of excitement and anticipation, as they prepare for the meeting. In

Conferences

Cardiologists share their perspective on The Medicines Co.'s inclisiran and other key events from AHA's 2019 Scientific Sessions

Following AHA 2019 Scientific Sessions, Novartis announced its intention to buy The Medicines Company for nearly $10B, based on promising results on its small interfering RNA (siRNA) therapy, inclisiran. The therapy targets PCSK9

Conferences

JAKs continue to capture attention, new MOAs stir excitement at ACR 2019

This year’s annual meeting held November 8-13 did not disappoint according to a ZoomRx survey with 35 rheumatologists who attended the conference.

Associate Principal Kat Lynch on working in a team-based environment and appreciating malaise-era cars.

Kat Lynch is an Associate Principal in our Boston office. She’s been at ZoomRx for over three years and has worked in pharma market intelligence for over 20. Kat’s deep understanding

Conferences

Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data

Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,

Promotional Tracking

Evaluating Print vs. Digital Aids in Oncology

Equipping reps with digital visual aids is a time and cost-intensive exercise. Consequently, sales leadership teams find themselves grappling with the questions: The conventional logic is that digital aids enable sales reps to